Consumer telehealth · Employer obesity management
Calibrate
Calibrate provides physician-guided obesity and metabolic health programs sold primarily to employers and health plans to manage outcomes and GLP-1 spend. It is not a hospital EHR.
Strong fit
- Employers and health plans that want an obesity program with coaching and results tracking that helps control GLP-1 drug costs
- Benefits leaders comparing metabolic health programs for employers, not consumer brands selling compounded semaglutide
- Organizations that want medication plus curriculum and coaching, not medication alone
Weak fit
- Individuals looking for the cheapest cash-pay compounded tirzepatide refill
- Health systems that will only refer into their own endocrinology department
- Buyers who need a population health data platform on their own servers, not a virtual care program
Bottom line
Calibrate is worth using for employers and health plans that want to manage obesity care and control GLP-1 spending for their members. It suits benefits teams ready to coordinate with their pharmacy benefit manager. Individuals who want one-to-one specialty clinic care may prefer Form Health.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Calibrate is a New York metabolic health company founded by Isabelle Kenyon and now led by CEO Rob Rebak. Its program combines physician oversight, a coaching curriculum, and medication when appropriate, along with reporting on results. In 2025 and 2026 it moved from selling mainly to consumers to selling mainly to employers and health plans, which now make up most of its customers.
That shift changed what matters. For employers, setting up Calibrate means coordinating with benefits teams and pharmacy benefit managers more than installing software.
How easily an individual can sign up matters less than it did when the company sold directly to consumers. Pricing comes through benefits contracts, which are usually not public.
Among weight care programs we review, Calibrate scores just below Form Health, which feels more like a one-to-one specialty clinic. It scores above cash-pay compounding services when the problem is the cost of GLP-1 drugs and keeping members on treatment.
Form Health suits buyers who want obesity medicine specialists. Found suits people who want a consumer weight-care brand, and Henry Meds suits members who only want low-cost compounded medications.
Calibrate's score reflects a solid fit for employers, held back by the usual lack of clarity in benefits contracts.
Competitor landscape
| Vendor | Overall | Ease of use |
|---|---|---|
| Allara Health | 7.7 | 7.8 |
| Form Health | 7.5 | 7.3 |
| Found | 7.4 | 7.2 |
| Calibrate | 7.3 | 7.1 |
| Eden | 7.3 | 7.2 |
| Fridays | 7.1 | 7.0 |
| Mochi Health | 7.0 | 6.6 |
| Nu Image Medical | 6.8 | 6.5 |
| Sesame | 6.8 | 6.7 |
| Henry Meds | 6.7 | 6.3 |
| GobyMeds | 6.6 | 6.5 |
Pricing
| Item | Detail |
|---|---|
| Model | An obesity program with coaching, bought by employers and health plans. Medication is billed separately through pharmacy benefits. |
| What usually drives cost | The number of people covered, how much clinical care is included, how often coaching happens, the reports you want, and how much work with your pharmacy benefit manager is needed. |
| What to ask before you buy | The fee per employee per month or per program, plus what you expect to pay for GLP-1 drugs under your formulary rules. |
| Published pricing | Employer pricing is quoted through calibratehealth.com and joincalibrate.com. There is no public consumer price list. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Calibrate to function | |
| A signed contract with an employer or health plan | Without one, there is no program to launch. |
| Pharmacy benefit and formulary rules that line up with the program | Otherwise you will miss your GLP-1 cost goals. |
| Published rules for who qualifies and who does not | Enrolling the wrong members leads to complaints. |
| A clear path from coaching to clinical care when needed | Using it only for medication misses the point of the program. |
| A named HR lead for communications | Few people enroll without outreach. |
| What will maximize your value | |
| Enroll your target group in the first 60 days | Slow enrollment wastes the contract year. |
| Report GLP-1 spending and whether members stay on treatment every month | Your finance team needs these numbers. |
| Follow up on delayed prior authorizations | Gaps in medication make members drop out. |
| Deal-breakers | |
| You are an individual who only wants compounded refills | |
| There is no employer or health plan paying for it | |
| You need a population health data warehouse on your own servers | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Contract and pharmacy benefit setup | 4-10 weeks |
| 2 | Member enrollment | 4-8 weeks |
| 3 | Reporting on results | Ongoing |
Leadership
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.